119 related articles for article (PubMed ID: 30748107)
1. Effects of azathioprine and its metabolites on inflammatory cytokines in human nasal polyp organ cultures.
Yeo NK; Park WJ; Eom DW; Oh MY; Lee JH
Int Forum Allergy Rhinol; 2019 Jun; 9(6):648-655. PubMed ID: 30748107
[TBL] [Abstract][Full Text] [Related]
2. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps.
Mullol J; Xaubet A; Gaya A; Roca-Ferrer J; López E; Fernàndez JC; Fernàndez MD; Picado C
Clin Exp Allergy; 1995 Jul; 25(7):607-15. PubMed ID: 8521179
[TBL] [Abstract][Full Text] [Related]
3. Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3.
Park SJ; Kim TH; Jun YJ; Lee SH; Ryu HY; Jung KJ; Jung JY; Hwang GH; Lee SH
J Allergy Clin Immunol; 2013 Mar; 131(3):772-80. PubMed ID: 23375208
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
von Borstel A; Abdulahad WH; Dekkema G; Rutgers A; Stegeman CA; Veldman J; Heeringa P; Sanders JS
PLoS One; 2020; 15(7):e0235743. PubMed ID: 32645052
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide induces pro-inflammatory cytokines and MMP production via TLR4 in nasal polyp-derived fibroblast and organ culture.
Cho JS; Kang JH; Um JY; Han IH; Park IH; Lee HM
PLoS One; 2014; 9(11):e90683. PubMed ID: 25390332
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the proinflammatory cytokine IL-18 in the formation of human nasal polyps.
Zhang G; Jing X; Wang X; Shi W; Sun P; Su C; Zhu M; Yang Z; Yao Z; Yang J
Anat Rec (Hoboken); 2011 Jun; 294(6):953-60. PubMed ID: 21538928
[TBL] [Abstract][Full Text] [Related]
7. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
Soh JS; Yun WJ; Kim KJ; Won CH; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
Inflamm Bowel Dis; 2015 Apr; 21(4):832-9. PubMed ID: 25789922
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate Induces Apoptosis in Organ-Cultured Nasal Polyps Via the Fas Pathway.
Heo KW; Park SK; Lee YM; Choe SH; Gu PM; Hong TU; Hur DY
J Craniofac Surg; 2017 May; 28(3):806-809. PubMed ID: 28468172
[TBL] [Abstract][Full Text] [Related]
9. Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps.
Lu X; Zhang XH; Wang H; Long XB; You XJ; Gao QX; Cui YH; Liu Z
Allergy; 2009 Jan; 64(1):104-11. PubMed ID: 19076536
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Treatment with 2-APB Inhibits the Inflammation in Nasal Polyps.
Lin L; Dai F; Chen Z; Cai L
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):461-7. PubMed ID: 26084825
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of CCL17 in the disrupted nasal polyp epithelium and its regulation by IL-4 and IL-5.
Kim B; Lee HJ; Im NR; Lee DY; Kim HK; Kang CY; Park IH; Lee SH; Lee HM; Lee SH; Baek SK; Kim TH
PLoS One; 2018; 13(5):e0197355. PubMed ID: 29746583
[TBL] [Abstract][Full Text] [Related]
12. Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps.
Liu Z; Lu X; Wang H; You XJ; Gao QX; Cui YH
Allergy; 2007 Sep; 62(9):999-1006. PubMed ID: 17578498
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokine levels in nasal fluid as indicators of severity of nasal polyposis.
Perić A; Vojvodić D; Radulović V; Vukomanović-Durdević B; Perić AV; Miljanović O
Acta Clin Croat; 2010 Dec; 49(4):395-403. PubMed ID: 21830450
[TBL] [Abstract][Full Text] [Related]
14. Non-Eosinophilic Nasal Polyps Shows Increased Epithelial Proliferation and Localized Disease Pattern in the Early Stage.
Kim DK; Jin HR; Eun KM; Mutusamy S; Cho SH; Oh S; Kim DW
PLoS One; 2015; 10(10):e0139945. PubMed ID: 26439628
[TBL] [Abstract][Full Text] [Related]
15. Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment.
Bolard F; Gosset P; Lamblin C; Bergoin C; Tonnel AB; Wallaert B
Allergy; 2001 Apr; 56(4):333-8. PubMed ID: 11284802
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
Belaiche J; Desager JP; Horsmans Y; Louis E
Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
[TBL] [Abstract][Full Text] [Related]
17. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
[TBL] [Abstract][Full Text] [Related]
18. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease.
Hamilos DL; Thawley SE; Kramper MA; Kamil A; Hamid QA
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):79-87. PubMed ID: 9893189
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
20. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
